Sacituzumab govitecan therapy – BIOENGINEER.ORG https://bioengineer.org Bioengineering Sun, 19 Oct 2025 07:21:52 +0000 en-US hourly 1 https://wordpress.org/?v=7.0 https://bioengineer.org/wp-content/uploads/2019/09/cropped-bioengineering-32x32.png Sacituzumab govitecan therapy – BIOENGINEER.ORG https://bioengineer.org 32 32 72741379 Antibody-Drug Conjugates Enhance Outcomes in Advanced Triple-Negative Breast Cancer Patients Unsuitable for Immune Checkpoint Inhibitors https://bioengineer.org/antibody-drug-conjugates-enhance-outcomes-in-advanced-triple-negative-breast-cancer-patients-unsuitable-for-immune-checkpoint-inhibitors/ Sun, 19 Oct 2025 07:21:35 +0000 https://bioengineer.org/antibody-drug-conjugates-enhance-outcomes-in-advanced-triple-negative-breast-cancer-patients-unsuitable-for-immune-checkpoint-inhibitors/ 283420